Sectoral Asset Management’s AgomAb Therapeutics NV AGMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-43,500
Closed -$565K – 92
2026
Q2
$565K Hold
43,500
– – 0.39% 58
2026
Q1
$477K Buy
+43,500
New +$616K 0.4% 58

Other funds holding AGMB

Sectoral Asset Management's AGMB Position: Q3 2026 in Review

Sectoral Asset Management sold out of AgomAb Therapeutics NV (AGMB) in Q3 2026, closing a stake of 43,500 shares — an estimated $565K sold.

Sectoral Asset Management first reported a position in AGMB in Q1 2026 and held it in 2 quarters. The position peaked at $565K in Q2 2026. 25 funds tracked by Wall St. Rank hold AGMB as of Q3 2026.

  • Sectoral Asset Management reported no remaining AgomAb Therapeutics NV position as of Q3 2026 after selling out during the quarter.
  • Sectoral Asset Management sold 43,500 AgomAb Therapeutics NV shares in Q3 2026, an estimated $565K.
  • Sectoral Asset Management first reported a position in AgomAb Therapeutics NV in Q1 2026 and held it in 2 quarters.
  • Sectoral Asset Management's AgomAb Therapeutics NV position peaked at $565K in Q2 2026.
  • 25 funds tracked by Wall St. Rank held AgomAb Therapeutics NV as of Q3 2026.

Based on Sectoral Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.